Delivery Order SPE2DB22D2206-SPE2DB25FFP55
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 UT VIAL 1S, a pharmaceutical product, with a ceiling value of $6,146.14 and a period of performance through May 8, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 unit vials, with a ceiling value of $1,117.48 and a performance period ending on June 9, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,822.36 firm fixed-price contract is for the delivery of XEOMIN 100 unit vials. The contract has an ultimate completion date of June 17, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 100 UT VIAL 1S, a medical supply, with a ceiling value of $13,968.50 and a performance period through June 13, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 50 unit vials, a pharmaceutical product, with a firm fixed price and a ceiling value of $1,215.76. The contract has an ultimate completion date of July 7, 2025 and was awarded on June 12, 2025. The contract is not set aside and was awarded through open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of XEOMIN 100 unit vials, a pharmaceutical product, at a firm fixed price of $44,036.16. The contract has an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XEOMIN 200 unit vials, a pharmaceutical product, with a ceiling value of $3,352.44 and a period of performance through February 28, 2025. The contract has a firm fixed-price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,934.16, is for the delivery of 4,568,096,981 units of XEOMIN 100 unit vials. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.40 firm fixed price contract is for the delivery of XEOMIN 50 unit vials and has an ultimate completion date of April 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XEOMIN 200 unit vials, a medication used for various medical conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,762.20 and a period of performance through June 10, 2025. It is not designated as a set-aside contract, indicating open...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FFP55Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $21,567.00, is for the delivery of XEOMIN 100 UNIT VIALS, a medical product. The contract type is Firm Fixed Price, with a period of performance ending on March 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract was not designated with a set-aside requirement. The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug Corp and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.6k | 2/12/25 |